EGFR and neoplasm: Some studies showed an association of EGFR immunoreactivity with well differentiated RCCs [38], or regarded strong membranous EGFR immunostaining as an indicator of good prognosis [39], whereas others showed an association of EGFR immunoreactivity with high tumor stage/grade and poor prognosis [40], or no significant associations at all [41].